Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| hepatocyte | 5 studies | 27% ± 8% | |
| epithelial cell of proximal tubule | 3 studies | 19% ± 3% | |
| astrocyte | 3 studies | 25% ± 4% |
Insufficient scRNA-seq data for expression of PIPOX at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 799.57 | 2636 / 2642 | 99% | 33.89 | 696 / 705 |
| liver | 100% | 16746.43 | 226 / 226 | 95% | 201.18 | 384 / 406 |
| kidney | 98% | 4738.99 | 87 / 89 | 58% | 10.02 | 527 / 901 |
| ovary | 48% | 62.94 | 87 / 180 | 70% | 9.35 | 300 / 430 |
| intestine | 81% | 348.28 | 782 / 966 | 33% | 4.56 | 172 / 527 |
| prostate | 89% | 209.82 | 217 / 245 | 15% | 0.67 | 76 / 502 |
| uterus | 81% | 189.61 | 137 / 170 | 19% | 1.85 | 86 / 459 |
| esophagus | 61% | 148.39 | 885 / 1445 | 18% | 1.86 | 33 / 183 |
| bladder | 62% | 185.14 | 13 / 21 | 16% | 2.40 | 80 / 504 |
| stomach | 38% | 103.69 | 135 / 359 | 40% | 5.28 | 113 / 286 |
| blood vessel | 65% | 88.06 | 864 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 62% | 97.46 | 150 / 241 | 0% | 0 | 0 / 0 |
| lung | 32% | 32.90 | 184 / 578 | 26% | 3.05 | 306 / 1155 |
| adrenal gland | 27% | 27.97 | 69 / 258 | 26% | 2.53 | 59 / 230 |
| skin | 39% | 49.97 | 698 / 1809 | 2% | 0.11 | 11 / 472 |
| peripheral blood | 32% | 67.22 | 293 / 929 | 0% | 0 | 0 / 0 |
| pancreas | 7% | 7.50 | 23 / 328 | 16% | 2.47 | 29 / 178 |
| adipose | 21% | 25.24 | 247 / 1204 | 0% | 0 | 0 / 0 |
| breast | 14% | 13.74 | 62 / 459 | 5% | 0.51 | 53 / 1118 |
| tonsil | 0% | 0 | 0 / 0 | 13% | 0.76 | 6 / 45 |
| muscle | 7% | 6.84 | 53 / 803 | 0% | 0 | 0 / 0 |
| thymus | 2% | 1.76 | 12 / 653 | 1% | 0.04 | 4 / 605 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.06 | 1 / 80 |
| heart | 1% | 0.89 | 5 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006554 | Biological process | lysine catabolic process |
| GO_0033514 | Biological process | L-lysine catabolic process to acetyl-CoA via L-pipecolate |
| GO_0005829 | Cellular component | cytosol |
| GO_0005782 | Cellular component | peroxisomal matrix |
| GO_0005777 | Cellular component | peroxisome |
| GO_0050031 | Molecular function | L-pipecolate oxidase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0050660 | Molecular function | flavin adenine dinucleotide binding |
| GO_0008115 | Molecular function | sarcosine oxidase activity |
| Gene name | PIPOX |
| Protein name | Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase) sarcosine oxidasee (formaldehyde-forming) (EC 1.5.3.1) |
| Synonyms | LPIPOX PSO |
| Description | FUNCTION: Metabolizes sarcosine and L-pipecolic acid. . |
| Accessions | K7EJU8 ENST00000469082.1 Q6IAJ9 Q8N6Z6 ENST00000323372.9 Q9P0Z9 ENST00000466889.5 K7EK30 |